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Following hard on the heels of the human
genome project, microbial genome
versions have now begun to produce vast
amounts of information on the nucleotide
sequences of specific microbes. How
useful is this information and how can
researchers wade through the millions of
base pairs of sequence data to find genes
or sequences of interest for either
diagnostic or therapeutic strategies? In
theory, the answer lies with the new
specialty of bioinformatics, which covers
genomics, proteomics and metabolomics
– terms that are more recognisable to
many as molecular genetics and
biochemistry. 
Many scientists have the impression that
once the genome of an organism is sequenced
then everything about it is known. But is this
really true? At this stage, it might be useful to
look at an organism whose genome has been
sequenced completely. Take Chlamydia
trachomatis serovar D, for example.
Chlamydia trachomatis
The C. trachomatis serovar D genome was
sequenced in 1998 and found to be 1.045
Mb in length. Full details of the genes
present, the proteins they encode and any
references can be obtained by logging on to
the TIGR website (www.TIGR.org) and then
clicking on the ‘Comprehensive microbial
resource’ and then the ‘Visit a CMR page for
an individual genome’ icons. This will reveal
the names of all the organisms cloned. In this
example, C. trachomatis serovar D would be
the destination, where everything that is
known about the genome of the organism
can be explored. 
So, if everything is known about 
C. trachomatis serovar D, why is work still
being undertaken on it? The truth is that
everything is known about the organism’s
nucleotide sequence and researchers can
predict that it codes for 877 proteins, 103 of
which are secreted as judged by the presence
of signal peptides and 241 have
transmembrane domains and therefore
appear to be membrane bound. However, the
function of more than 20% of the proteins
remains a mystery.
One way to identify genes is by their
homology with other cloned genes, on the
assumption that bacteria must have evolved
from each other and therefore will share
genes, albeit with some changes that have
resulted from evolution. To observe such
homology, an alignment search facility such
as BLAST (basic local alignment search tool)
can be used, which permits comparison of
nucleotides or derived proteins from 
C. trachomatis serovar D with all other genes
or proteins lodged in databases worldwide or
with subsets (eg prokaryotic genes and
proteins) of that data. 
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The appearance of Chlamydia trachomatis infection in a cervical smear. 
The C. trachomatis serovar D genome was sequenced in 1998. 
‘One way to identify genes is by their
homology with other cloned genes’
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Vast amounts of data are now available on individual microbial species
through the application of molecular techniques such as genomics, proteomics
and metabolomics. Here, Pamela Greenwell and Sanjiv Rughooputh consider
the value of the information obtained and how it can be understood.
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The results show areas of homology as
alignments and give the statistical probability
that the homology is significant and not due
to chance. However, work tends to be done
with the translated amino acids that are
derived from the nucleotide sequences
because different organisms do have different
codon preferences that can make nucleotide
comparisons difficult. 
Of course, as the databases contain billions
of sequences it might be expected that most
proteins could be identified by their
homology to other known proteins. This,
however, is not the case, as has been seen
with C. trachomatis serovar D. Is it an
unusual microbe? No, Trichomonas vaginalis
has also been studied and this has shown that
most of its cloned genes encode proteins
with little homology to other cloned genes.
Widening the focus
So, does this mean that bioinformatics is not
useful? Although it is not possible to identify
all genes by this method, some proteins can
be identified and then other useful data can
be derived from them. For example, when
proteins encoded by C. trachomatis serovar D
genes were compared to those of Escherichia
coli and Bacillus subtilis, 195 showed better
homology with E. coli proteins, whereas 259
showed greater homology with those of 
B. subtilis. 
This implies that C. trachomatis serovar D
has characteristics of both Gram-positive and
Gram-negative organisms. When C.
trachomatis serovar D proteins were
compared to those of other sexually
transmitted organisms (eg Treponema
pallidum and Mycoplasma genitalium), 
68 of the encoded C. trachomatis serovar D
proteins showed homology with M.
genitalium proteins and 286 showed
homology with T. pallidum proteins. 
However, the majority of C. trachomatis
serovar D proteins show no similarity with
those produced by either of the organisms.
Nonetheless, the proteins that are conserved
between these organisms may be of great
interest as targets for therapeutics strategies
against more than one organism
simultaneously. 
Genomic comparison
One of the most useful tools for the
molecular microbiologist is whole genome
comparison, using traditional tools such as
BLAST. To achieve the best visualisation,
however, Artemis
(www.sanger.ac.uk/Software/Artemis/) 
is the tool of choice, with ACT
(www.sanger.ac.uk/Software/ACT/) 
required for whole genome comparison. 
ACT permits direct comparison of two
genomes and, in the case of mycobacteria,
has shown that Mycobacterium leprae and 
M. tuberculosis originally had similar
genomes, but that M. leprae went on to lose
genes, which resulted in its current smaller
size. However, small fragments of these lost
genes are still visible using ACT. 
In other organisms, comparisons of
pathogenic and non-pathogenic bacteria have
highlighted the presence of pathogenicity
islands, which can be investigated as
potential therapeutics targets. Similarly, the
evolution of antibiotic resistance can be
studied and areas of the microbial genome
suitable as diagnostic targets can be
determined. 
In addition, nucleotide information permits
the identification of specific areas of the
genome and tools are available (www-
genome.wi.mit.edu/cgi-
bin/primer/primer3_www.cgi) for designing
primers for polymerase chain reaction (PCR)-
based detection.
Leading question
So, is bioinformatics useful? Yes, but it
cannot tell the whole story. It is simply a
tool, albeit a very powerful one, to aid the
understanding of microbial genomes. 
In conclusion, it is interesting to ponder
the value of the human genome project in
light of the limitations found with microbial
analysis. Clearly, the take-home message
must be, ‘you can know everything about the
nucleotides in the genome, but that does not
mean that you know everything about the
organism’. n
Dr Pamela Greenwell and Dr Sanjiv
Rughooputh are members of the Molecular
and Medical Microbiology Research Group
at the School of Biosciences, University of
Westminster, London. 
Comparisons of
pathogenic and non-
pathogenic bacteria
have highlighted the
presence of
pathogenicity islands’
